Description

Specifications

• Form: White lyophilized powder, tri-peptide blend
• Standard vial size: 70mg total (10mg BPC-157 / 10mg TB-500 / 50mg GHK-Cu)
• Purity: ≥99% each peptide (HPLC & Mass Spec verified)
• Storage: Store lyophilized powder at -20°C; refrigerate at 2–8°C once reconstituted

Overview

The GLOW blend combines two systemic tissue-repair peptides (BPC-157, TB-500) with a dermal-remodeling copper peptide (GHK-Cu), designed for researchers studying the intersection of systemic tissue repair and localized dermal matrix regeneration.

Mechanism & Research Findings

This blend allows investigators to study three complementary repair pathways in a single protocol: BPC-157’s angiogenic/NO-pathway signaling, TB-500’s actin-mediated cell migration, and GHK-Cu’s collagen-synthesis and MMP-remodeling activity in dermal tissue. Combination research of this kind is used to characterize whether systemic and localized repair pathways produce additive effects on connective-tissue and dermal outcome measures compared to single-peptide protocols.

Research Applications

• Combined systemic + dermal tissue-repair pathway research
• Multi-peptide synergy studies
• Comparative connective-tissue and dermal-matrix research

For laboratory research use only. Not for human consumption, diagnostic, or therapeutic use.